“…The low bioavailability is caused by many factors, including low water solubility and slow dissolution rate, poor permeability, or rapid metabolism and elimination rate (He et al, 2015). Many new dosage forms, such as inclusion complexes (J. Wang et al, 2019), solid dispersions (Tran & Tran, 2020), microcapsules (Zhang et al, 2021), microspheres (Ghosh Dastidar et al, 2018), nanoparticles (Kim et al, 2018), and liposomes (Y. Wang et al, 2022), have been developed to improve the bioavailability. By encapsulating the drugs within these novel carrier systems, an increased elimination half‐life and decreased adverse reactions might be achieved (Bikram & West, 2008).…”